Connection

Contact Us
If you have any questions or feedback please contact us.

Search Results to John R Corboy

This is a "connection" page, showing the details of why an item matched the keywords from your search.

Search Results

Corboy, John

One or more keywords matched the following items that are connected to Corboy, John

Item Type	Name
Academic Article	Anti-DNA antibodies are a major component of the intrathecal B cell response in multiple sclerosis.
Academic Article	High-dose immunosuppressive therapy and autologous peripheral blood stem cell transplantation for severe multiple sclerosis.
Academic Article	Characterizing the mechanisms of progression in multiple sclerosis: evidence and new hypotheses for future directions.
Academic Article	Most patients with multiple sclerosis or a clinically isolated demyelinating syndrome should be treated at the time of diagnosis.
Academic Article	Identification of fibers at risk for degeneration by diffusion tractography in patients at high risk for MS after a clinically isolated syndrome.
Academic Article	Immunomodulatory therapy in multiple sclerosis and breast cancer risk: a case report and literature review.
Academic Article	How the conflict between American psychiatry and neurology delayed the appreciation of cognitive dysfunction in multiple sclerosis.
Academic Article	Therapeutic options in multiple sclerosis: five new things.
Academic Article	Use of diagnostic tests and procedures for disease-modifying therapy users and non-disease-modifying therapy users with multiple sclerosis.
Academic Article	Emerging therapies for treatment of multiple sclerosis.
Academic Article	Update on PML and PML-IRIS occurring in multiple sclerosis patients treated with natalizumab.
Academic Article	Comparative effectiveness of early natalizumab treatment in JC virus-negative relapsing-remitting multiple sclerosis.
Academic Article	The utility of MRI in suspected MS: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology.
Academic Article	Oral simvastatin treatment in relapsing-remitting multiple sclerosis.
Academic Article	Comparative analysis of the CD19+ and CD138+ cell antibody repertoires in the cerebrospinal fluid of patients with multiple sclerosis.
Academic Article	Multiple sclerosis pathology in the normal and abnormal appearing white matter of the corpus callosum by diffusion tensor imaging.
Academic Article	Therapeutic considerations for disease progression in multiple sclerosis: evidence, experience, and future expectations.
Academic Article	Single-cell repertoire analysis demonstrates that clonal expansion is a prominent feature of the B cell response in multiple sclerosis cerebrospinal fluid.
Academic Article	Accuracy of clinical detection of INO in MS: corroboration with quantitative infrared oculography.
Academic Article	MS vs. HD: can white matter and subcortical gray matter pathology be distinguished neuropsychologically?
Academic Article	Initial evaluations for multiple sclerosis in a university multiple sclerosis center: outcomes and role of magnetic resonance imaging in referral.
Academic Article	The differential diagnosis of Axis I psychopathology presenting to a university-based multiple sclerosis clinic.
Academic Article	VH4 gene segments dominate the intrathecal humoral immune response in multiple sclerosis.
Academic Article	Factors that influence adherence with disease-modifying therapy in MS.
Academic Article	Natalizumab-associated complication? First case of peripheral T cell lymphoma.
Academic Article	The association between multiple sclerosis-related fatigue and balance as a function of central sensory integration.
Academic Article	Effects of vestibular rehabilitation on multiple sclerosis-related fatigue and upright postural control: a randomized controlled trial.
Concept	Diffuse Cerebral Sclerosis of Schilder
Concept	Multiple Sclerosis, Relapsing-Remitting
Concept	Multiple Sclerosis, Chronic Progressive
Concept	Multiple Sclerosis
Academic Article	The nature of verbal memory impairment in multiple sclerosis: a list-learning and meta-analytic study.
Academic Article	Defining a new biomarker for the autoimmune component of Multiple Sclerosis: Th40 cells.
Academic Article	Increased relapse activity for multiple sclerosis natalizumab users who become nonpersistent: a retrospective study.
Academic Article	Burden of multiple sclerosis on direct, indirect costs and quality of life: National US estimates.
Academic Article	Human placenta-derived cells (PDA-001) for the treatment of adults with multiple sclerosis: a randomized, placebo-controlled, multiple-dose study.
Academic Article	Patient perspectives on physician conflict of interest in industry-sponsored clinical trials for multiple sclerosis therapeutics.
Academic Article	Estriol combined with glatiramer acetate for women with relapsing-remitting multiple sclerosis: a randomised, placebo-controlled, phase 2 trial.
Academic Article	Multiple sclerosis prevalence in the United States commercially insured population.
Academic Article	Physician compensation for industry-sponsored clinical trials in multiple sclerosis influences patient trust.
Academic Article	Disease-modifying Therapies for Multiple Sclerosis.
Academic Article	Bal? concentric sclerosis evolving from apparent tumefactive demyelination.
Academic Article	Disease-modifying therapies can be safely discontinued in an individual with stable relapsing-remitting MS - Commentary.
Academic Article	The tension between early diagnosis and misdiagnosis of multiple sclerosis.
Academic Article	Comparison of fingolimod and dimethyl fumarate in the treatment of multiple sclerosis: Two-year experience.
Academic Article	Efficacy of Balance and Eye-Movement Exercises for Persons With Multiple Sclerosis (BEEMS).
Academic Article	Epstein-Barr virus is present in the brain of most cases of multiple sclerosis and may engage more than just B cells.
Academic Article	Comment on 2018 American Academy of Neurology guidelines on disease-modifying therapies in MS.
Academic Article	The impact of very short transition times on switching from Natalizumab to Fingolimod on imaging and clinical effectiveness outcomes in multiple sclerosis.
Academic Article	Adjustments in Torque Steadiness During Fatiguing Contractions Are Inversely Correlated With IQ in Persons With Multiple Sclerosis.
Academic Article	Rituximab vs placebo induction prior to glatiramer acetate monotherapy in multiple sclerosis.
Academic Article	Autologous Hematopoietic Cell Transplantation for Treatment-Refractory Relapsing Multiple Sclerosis: Position Statement from the American Society for Blood and Marrow Transplantation.
Academic Article	Natalizumab versus fingolimod and dimethyl fumarate in multiple sclerosis treatment.
Academic Article	Monitoring, Switching, and Stopping Multiple Sclerosis Disease-Modifying Therapies.
Academic Article	Another sphingosine 1-phosphate receptor modulator for the treatment of patients with multiple sclerosis.
Academic Article	Rituximab-induced serum sickness in multiple sclerosis patients.
Academic Article	Comparative discontinuation, effectiveness, and switching practices of dimethyl fumarate and fingolimod at 36-month follow-up.
Academic Article	Rituximab versus natalizumab, fingolimod, and dimethyl fumarate in multiple sclerosis treatment.
Academic Article	Serious safety events in rituximab-treated multiple sclerosis and related disorders.
Academic Article	Efficacy and Safety of 2 Fingolimod Doses vs Glatiramer Acetate for the Treatment of Patients With Relapsing-Remitting Multiple Sclerosis: A Randomized Clinical Trial.
Academic Article	Brain Atrophy Rates for Stable Multiple Sclerosis Patients on Long-Term Fingolimod versus Glatiramer Acetate.
Academic Article	Discontinuation of Disease-Modifying Therapy in Multiple Sclerosis: Should We Stay or Should We Go?
Academic Article	Correspondence to: Humoral immune response to COVID-19 mRNA vaccine in patients with multiple sclerosis treated with high-efficacy disease-modifying therapies.
Academic Article	Brain atrophy rates in patients with multiple sclerosis on long term natalizumab resembles healthy controls.
Academic Article	Evolution of Disease Modifying Therapy Benefits and Risks: An Argument for De-escalation as a Treatment Paradigm for Patients With Multiple Sclerosis.
Academic Article	Challenging Cases in Neuroimmunology.
Academic Article	Safety and patient experience with at-home infusion of ocrelizumab for multiple sclerosis.
Academic Article	Risk of new disease activity in patients with multiple sclerosis who continue or discontinue disease-modifying therapies (DISCOMS): a multicentre, randomised, single-blind, phase 4, non-inferiority trial.
Academic Article	TMEM106B Puncta Is Increased in Multiple Sclerosis Plaques, and Reduced Protein in Mice Results in Delayed Lipid Clearance Following CNS Injury.
Academic Article	Differential diagnosis of suspected multiple sclerosis: an updated consensus approach.
Academic Article	Comparative Efficacy of Disease-Modifying Treatments for Relapsing Multiple Sclerosis-Variations in Real-World Experience.

Search Criteria

Sclerosis